Goserelin
Pharmaceutical-grade Goserelin Acetate (CAS 65807-02-5), ≥98.0% HPLC, ≥80% peptide content, supplied wholesale by Zyntex to licensed producers. GnRH agonist peptide API for long-acting PLGA implants. CoA and SDS.
Description
Goserelin Acetate Product Overview
Goserelin is a synthetic decapeptide analogue of gonadotropin-releasing hormone (GnRH). As the acetate salt (CAS 145781-92-6), it is a white to off-white lyophilized powder with a peptide content of at least 80%.
Its main dosage form is a biodegradable implant in which the peptide is dispersed in a polylactide-co-glycolide (PLGA) matrix and injected under the skin, releasing the peptide over one or three months. Pharmaceutical companies use it in oncology and gynecology; in prostate cancer protocols it is sometimes combined with antiandrogens such as Flutamide.
Implant production requires precise control of peptide content, particle properties and endotoxins. Zyntex supplies goserelin acetate from qualified peptide API producers, only to licensed pharmaceutical companies. Related peptide APIs include Ganirelix and Lanreotide.
Key Applications of Goserelin Acetate
Main application areas:
💉 Depot Implants
Peptide API for PLGA-based implants.
🏥 Oncology
API for hormone-dependent cancer therapies.
🩺 Gynecology
API for gynecological indications.
🔬 Generic Development
Development material for complex depot products.
Goserelin Acetate Technical Specifications
| Parameter | Standard Value |
|---|---|
| Product Name | Goserelin Acetate |
| CAS Number | 65807-02-5 (acetate: 145781-92-6) |
| Purity (HPLC) | ≥ 98.0% |
| Appearance | White to off-white lyophilized powder |
| Peptide Content | ≥ 80.0% |
| Acetate Content | ≤ 15.0% |
| Documents | CoA and SDS with every lot |
⚠️ Safety & Handling: Potent peptide hormone that may damage fertility or the unborn child. Avoid inhalation, ingestion and contact with skin and eyes; handle with gloves, eye protection and respiratory protection in a controlled environment. Store tightly closed and refrigerated or frozen. Always consult the Safety Data Sheet (SDS) for full classification and handling instructions.
Frequently Asked Questions
In which dosage form is it mainly used?
Mainly as a biodegradable PLGA implant injected under the skin, which releases the peptide over one or three months.
Who can purchase this API?
It is supplied only to pharmaceutical companies holding the licenses required for API purchase and use in their country.
How can I get a price and documents?
Prices depend on quantity, packaging and destination. Contact us with your required volume to receive a quotation together with the CoA and SDS.
